Lipid levels in patients hospitalized with coronary artery disease: An analysis of 136,905 hospitalizations in Get With The Guidelines

American Heart Journal

Volumn 157, Issue 1, 2009, Pages

  Sachdeva, Amit ^a   Cannon, Christopher P ^b   Deedwania, Prakash C ^c   LaBresh, Kenneth A ^d   Smith Jr , Sidney C ^e   Dai, David ^f   Hernandez, Adrian ^f   Fonarow, Gregg C ^a  

^a UCLA MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MassPRO   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; COMORBIDITY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UNSTABLE ANGINA PECTORIS;

EID: 57149144229     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.08.010     Document Type: Article

References (15)

1. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation 106 (2002) 3143-3421
2. Grundy S.M., Cleeman J.I., Merz C.N.B., et al., for the Coordinating Committee of the National Cholesterol Education Program and Endorsed by the National Heart, Lung, and Blood Institute, American College of Cardiology Foundation, and American Heart Association. Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation 110 (2004) 227-239
3. Carroll M.D., Lacher D.A., Sorlie P.D., et al. Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA 294 (2005) 1773-1781
4. LaBresh K.A., Ellrodt A.G., Gliklich R., et al. Get With The Guidelines for cardiovascular secondary prevention: pilot results. Arch Intern Med 164 (2004) 203-209
5. Cannon C.P., Braunwald E., McCabe C.H., et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350 (2004) 1495-1504
6. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360 (2002) 7-22
7. Castelli W. Cholesterol and lipids in the risk of coronary artery disease-the Framingham Heart Study. Can J Cardiol 4 Suppl A (1988) 5a-10a
8. Ansell B.J., Watson K.E., Fogelman A.M., et al. High-density lipoprotein function: recent advances. J Am Coll Cardiol 46 (2005) 1792-1798
9. Eckel R.H., Grundy S.M., and Zimmet P.Z. The metabolic syndrome. Lancet 365 (2005) 1415-1428
10. Gregg E.W., Cheng Y.J., Cadwell B.J., et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA 293 (2005) 1868-1874
11. Davidson M.H., Maki K.C., Pearson T.A., et al. Results of the National Cholesterol Education (NCEP) Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE) II Survey and Implications for Treatment Under the Recent NCEP Writing Group Recommendations. Am J Cardiol 96 (2005) 556-563
12. Pearson T.A., Laurora I., Chu H., et al. The Lipid Treatment Assessment Project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med 160 (2000) 459-467
13. Dodds C., and Mills G.L. Influence of myocardial infarction on plasma-lipoprotein concentration. Lancet 1 (1959) 1160-1163
14. Pfohl M., Schreiber I., Liebich H.M., et al. Upregulation of cholesterol synthesis after acute myocardial infarction-is cholesterol a positive acute phase reactant?. Atherosclerosis 142 (1999) 389-393
15. Pitt B., Loscalzo, Ycas J., et al. Lipid levels after acute coronary syndromes. J Am Coll Cardiol 51 (2008) 1440-1445